Cite
MLA Citation
Patrizia Nanni et al.. “OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis.” Oncoimmunology, vol. 7, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100068019142.0x000009